Skip to main content
Watch Insiders
Market intelligence
PTCTHealthcare

PTC Therapeutics Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 14, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 14, 2026Michael SchmertzlerDirectorSale2,500$59.61$149,037
Oct 9, 2026Mark Elliott BouldingEXEC. VP AND CLOSale192$64.26$12,338
Oct 7, 2026Michael SchmertzlerDirectorSale2,500$63.39$158,480
🔒 Unlock Real-Time Alerts and 2 More High-Conviction Rows — Subscribe to Watch Insiders Premium